Corrigendum to “Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study” [IBRO Neurosci. Rep. 15 (2023), pp. 90–99]

Detalles Bibliográficos
Autores principales: Raghavan, Kadalraja, Dedeepiya, Vidyasagar Devaprasad, Srinivasan, Subramaniam, Pushkala, Subramanian, Bharatidasan, Sudhakar S., Ikewaki, Nobunao, Iwasaki, Masaru, Senthilkumar, Rajappa, Preethy, Senthilkumar, Abraham, Samuel J.K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428020/
https://www.ncbi.nlm.nih.gov/pubmed/37593322
http://dx.doi.org/10.1016/j.ibneur.2023.08.001
_version_ 1785090372206067712
author Raghavan, Kadalraja
Dedeepiya, Vidyasagar Devaprasad
Srinivasan, Subramaniam
Pushkala, Subramanian
Bharatidasan, Sudhakar S.
Ikewaki, Nobunao
Iwasaki, Masaru
Senthilkumar, Rajappa
Preethy, Senthilkumar
Abraham, Samuel J.K.
author_facet Raghavan, Kadalraja
Dedeepiya, Vidyasagar Devaprasad
Srinivasan, Subramaniam
Pushkala, Subramanian
Bharatidasan, Sudhakar S.
Ikewaki, Nobunao
Iwasaki, Masaru
Senthilkumar, Rajappa
Preethy, Senthilkumar
Abraham, Samuel J.K.
author_sort Raghavan, Kadalraja
collection PubMed
description
format Online
Article
Text
id pubmed-10428020
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-104280202023-08-17 Corrigendum to “Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study” [IBRO Neurosci. Rep. 15 (2023), pp. 90–99] Raghavan, Kadalraja Dedeepiya, Vidyasagar Devaprasad Srinivasan, Subramaniam Pushkala, Subramanian Bharatidasan, Sudhakar S. Ikewaki, Nobunao Iwasaki, Masaru Senthilkumar, Rajappa Preethy, Senthilkumar Abraham, Samuel J.K. IBRO Neurosci Rep Corrigendum Elsevier 2023-08-09 /pmc/articles/PMC10428020/ /pubmed/37593322 http://dx.doi.org/10.1016/j.ibneur.2023.08.001 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Corrigendum
Raghavan, Kadalraja
Dedeepiya, Vidyasagar Devaprasad
Srinivasan, Subramaniam
Pushkala, Subramanian
Bharatidasan, Sudhakar S.
Ikewaki, Nobunao
Iwasaki, Masaru
Senthilkumar, Rajappa
Preethy, Senthilkumar
Abraham, Samuel J.K.
Corrigendum to “Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study” [IBRO Neurosci. Rep. 15 (2023), pp. 90–99]
title Corrigendum to “Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study” [IBRO Neurosci. Rep. 15 (2023), pp. 90–99]
title_full Corrigendum to “Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study” [IBRO Neurosci. Rep. 15 (2023), pp. 90–99]
title_fullStr Corrigendum to “Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study” [IBRO Neurosci. Rep. 15 (2023), pp. 90–99]
title_full_unstemmed Corrigendum to “Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study” [IBRO Neurosci. Rep. 15 (2023), pp. 90–99]
title_short Corrigendum to “Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study” [IBRO Neurosci. Rep. 15 (2023), pp. 90–99]
title_sort corrigendum to “beneficial immune-modulatory effects of the n-163 strain of aureobasidium pullulans-produced 1,3-1,6 beta glucans in duchenne muscular dystrophy: results of an open-label, prospective, exploratory case-control clinical study” [ibro neurosci. rep. 15 (2023), pp. 90–99]
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428020/
https://www.ncbi.nlm.nih.gov/pubmed/37593322
http://dx.doi.org/10.1016/j.ibneur.2023.08.001
work_keys_str_mv AT raghavankadalraja corrigendumtobeneficialimmunemodulatoryeffectsofthen163strainofaureobasidiumpullulansproduced1316betaglucansinduchennemusculardystrophyresultsofanopenlabelprospectiveexploratorycasecontrolclinicalstudyibroneuroscirep152023pp9099
AT dedeepiyavidyasagardevaprasad corrigendumtobeneficialimmunemodulatoryeffectsofthen163strainofaureobasidiumpullulansproduced1316betaglucansinduchennemusculardystrophyresultsofanopenlabelprospectiveexploratorycasecontrolclinicalstudyibroneuroscirep152023pp9099
AT srinivasansubramaniam corrigendumtobeneficialimmunemodulatoryeffectsofthen163strainofaureobasidiumpullulansproduced1316betaglucansinduchennemusculardystrophyresultsofanopenlabelprospectiveexploratorycasecontrolclinicalstudyibroneuroscirep152023pp9099
AT pushkalasubramanian corrigendumtobeneficialimmunemodulatoryeffectsofthen163strainofaureobasidiumpullulansproduced1316betaglucansinduchennemusculardystrophyresultsofanopenlabelprospectiveexploratorycasecontrolclinicalstudyibroneuroscirep152023pp9099
AT bharatidasansudhakars corrigendumtobeneficialimmunemodulatoryeffectsofthen163strainofaureobasidiumpullulansproduced1316betaglucansinduchennemusculardystrophyresultsofanopenlabelprospectiveexploratorycasecontrolclinicalstudyibroneuroscirep152023pp9099
AT ikewakinobunao corrigendumtobeneficialimmunemodulatoryeffectsofthen163strainofaureobasidiumpullulansproduced1316betaglucansinduchennemusculardystrophyresultsofanopenlabelprospectiveexploratorycasecontrolclinicalstudyibroneuroscirep152023pp9099
AT iwasakimasaru corrigendumtobeneficialimmunemodulatoryeffectsofthen163strainofaureobasidiumpullulansproduced1316betaglucansinduchennemusculardystrophyresultsofanopenlabelprospectiveexploratorycasecontrolclinicalstudyibroneuroscirep152023pp9099
AT senthilkumarrajappa corrigendumtobeneficialimmunemodulatoryeffectsofthen163strainofaureobasidiumpullulansproduced1316betaglucansinduchennemusculardystrophyresultsofanopenlabelprospectiveexploratorycasecontrolclinicalstudyibroneuroscirep152023pp9099
AT preethysenthilkumar corrigendumtobeneficialimmunemodulatoryeffectsofthen163strainofaureobasidiumpullulansproduced1316betaglucansinduchennemusculardystrophyresultsofanopenlabelprospectiveexploratorycasecontrolclinicalstudyibroneuroscirep152023pp9099
AT abrahamsamueljk corrigendumtobeneficialimmunemodulatoryeffectsofthen163strainofaureobasidiumpullulansproduced1316betaglucansinduchennemusculardystrophyresultsofanopenlabelprospectiveexploratorycasecontrolclinicalstudyibroneuroscirep152023pp9099

Ejemplares similares